523Wire StoriesAustralasian Inter-Service Incident Management System (AIIMS) Tecnologies & Tools – Main Players Analysis – 2022 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Australasian Inter-Service Incident Management System (AIIMS) Tecnologies & Tools – Main Players Analysis – 2022 Report” report has been added...
- 670Wire Stories
Asahi Kasei Starts Selling BR and S-SBR Made Using the Mass-balance Method
— Toward achievement of sustainability — NEW YORK & DÜSSELDORF, Germany & TOKYO–(BUSINESS WIRE)–#asahikasei–Asahi Kasei, a diversified Japanese multinational company, will begin...
- 480Wire Stories
ASTER_Wise Solution to Serve the Smart Community in Indonesia
AR/VR interactive caring and epidemic prevention are advanced smart technologies JAKARTA TIMUR, Indonesia–(BUSINESS WIRE)–ASTER_Wise Smart Community Theme Alliance organizes Taiwanese manufacturers such...
- 531Wire Stories
City of Tampere: Finland in Co-operation With Japan in Human-Centred Smart Urban Development
TAMPERE, Finland–(BUSINESS WIRE)–#AuroraAI–Tampere, one of Finland’s largest cities, is the first in Europe to introduce the Liveable Well-Being City indicators, which Japan...
- 511Wire Stories
Marinus Pharmaceuticals Announces Collaboration with Tenacia Biotechnology for Ganaxolone Development and Commercialization in China
Collaboration leverages Tenacia’s CNS, R&D, and local market expertise to support expansion of ganaxolone’s development programs and potentially provide additional access to...
- 735Wire Stories
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL)
BRUKINSA is the only Bruton’s Tyrosine Kinase (BTK) inhibitor to achieve superiority over IMBRUVICA® (ibrutinib) in relapsed/refractory CLL. BRUKINSA also showed superiority...
- 683Wire Stories
Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction
AZR-MD-001 0.5% meets co-primary efficacy endpoints, making it the first investigational drug to show significant improvements in both signs and symptoms of...
- 512Wire Stories
Genius Group to Announce Third Quarter 2022 Financial Results
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), will announce third quarter 2022 financial results on Wednesday,...
- 597Wire Stories
Alibaba Group Announces September Quarter 2022 Results
HANGZHOU, China–(BUSINESS WIRE)–$BABA #alibaba–Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988, “Alibaba” or “Alibaba Group”) today announced its financial results for...
- 474Wire Stories
Singapore Bunker Fuel (High Sulfur Fuel Oil, Low Sulfur Fuel Oil, Marine Gas Oil) Markets, Competition, Forecast & Opportunities, 2017-2021 & 2022-2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Singapore Bunker Fuel Market By Type (High Sulfur Fuel Oil, Low Sulfur Fuel Oil, Marine Gas Oil, and Others), By...
